ALBUQUERQUE, N.M.--(BUSINESS WIRE)--IntelliCyt, a leading provider of integrated platforms that accelerate drug discovery, antibody screening and immuno-oncology research, today announced record sales results for 2015. The successful launch of the iQue® Screener PLUS system as well as increased sales of the company’s other instrumentation, software and reagent products resulted in sales growth of 68 percent for the year.
